Skip to main content
. Author manuscript; available in PMC: 2013 Aug 19.
Published in final edited form as: Arch Neurol. 2012 Aug;69(8):1039–1043. doi: 10.1001/archneurol.2012.249

Table 1.

Table Comparison of Selected Studies Reporting Sex and Age Distribution for Patients With Neuromyelitis Optica or Aquaporin-4 Autoimmunity

Source Inclusion Criteria Study Population (Patients, No.) Female:Male Ratio Onset Age, y Positive AQP4-IgG Status, %
Collongues et al,7 2010 Clinical diagnosis5 Adult (125) 3:1 Mean, 34.5 (range, 4–66)a 54b
Rivera et al,9 2008 Clinical diagnosis1 Adult (34) 2.4:1 Mean, 34 Not tested
Bichuetti et al,10 2009 Mostly clinical Adult (41) 2.4:1 Mean, 32.6 (range, 20–60) 41c
Ghezzi et al,8 2004 Clinical diagnosis Adult, pediatric (46) 4.1:1 Mean ± SD, 40 ± 16.3 (range, 12–77) Not tested
Wingerchuk and Weinshenker,6 2003 Clinical diagnosis1 Adult, pediatric (80) 2.5:1 Median, 29 (monophasic) or 41 (relapsing) Not tested
Jarius et al,12 2011 AQP4-IgG seropositivity Adult, pediatric (89) 12.1:1 Median, 39.5 (range, 14–79)d 100
Nagaishi et al,11 2011 AQP4-IgG seropositivity Adult, pediatric (583) 10.7:1 Median, 44 (range, 3–86) 100
McKeon et al,13 2008 AQP4-IgG seropositivity Pediatric (88) 7:1 Median, 12 (range, 4–18) 100
Current study AQP4-IgG seropositivity Adult, pediatric (56 464) Unadjusted, 8.1:1; adjusted, 3.6:1 Mean, 46 (16)d 100

Abbreviation: AQP4, aquaporin-4.

a

Among the patients, 9.6% had onset before age 18 years and 16% had onset after age 50 years.

b

A total of 111 patients were tested.

c

A total of 17 patients were tested.

d

Refers to patient age at the time of AQP4-IgG testing.